Error

There is a problem with one of the content items on this page. The affected component type is:

Staff Profile Main Details

The system reports the following message:

No records found

I am a Senior Research Fellow at the Swansea Centre for Health Economics (SCHE), Swansea University. I started my academic career as a Lecturer in Statistics in 1995. I have about 20 years of experience in academic teaching and research in areas of statistics, demography, operational research and health economics. My research covers economic evaluation of healthcare programmes and health technology assessment, economic evaluations alongside RCTs, decision analytical modelling, application of OR tools in HE, and more recently have grown interests in modelling antibiotic resistance. I teach health economics and decisional modelling (graduate and post-graduate levels) on various courses at Cardiff and Swansea Universities and currently co-supervise three PhD projects. I have degrees in Statistics (MSc), Health Economics and Health policy (MSc) and Operational Research (PhD). Externally, I have been acting as a health economist on the New Medicine Group (NMG) to provide evidence from appraisals of new drugs to All Wales Medicine Strategy Group (AWMSG). I was on the editorial board of the AIUB Journal of Business and Economics (AJBE) during 2010-2014. I am a reviewer for NIHR HTA and Public Health Programme, European Journal of Public Health, Value in Health, PLOS ONE, BMC Public Health, BMC Health Services Research, Simulation Modelling Practice and Theory.

Areas of Expertise

  • Economic evaluation of health care programmes and health technology assessment
  • Decision analytical modelling
  • Economics of interventions to reduce antibiotic prescribing/resistance
  • Application of OR tools in health economics
  • Methodological research in cost-effectiveness analysis
  • economteric modelling.

Publications

  1. et. al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. The Lancet Gastroenterology & Hepatology 1(1), 15-24.
  2. & Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Health Technology Assessment 20(44), 1-320.
  3. & A feasibility randomised controlled trial of a motivational interviewing-based intervention for weight loss maintenance in adults. Health Technology Assessment 19(50), 1-378.
  4. All-Wales Licensed Premises Intervention (AWLPI): a randomised controlled trial of an intervention to reduce alcohol-related violence. Public Health Research 3(10), 1-152.
  5. Managing Common Infections in Primary Care: Economic Evaluation of Interventions Targeting Antibiotic Prescribing. Health Economics and Outcome Research: Open Access 1(1)

See more...

Supervision

  • Effects of Rehabilitation on Cardiac patients' health-related quality of life in Kuwait: Role of exercise, culture and socioeconomic factors (current)

    Student name:
    PhD
    Other supervisor: Dr Dareyoush Rassi
    Other supervisor: Dr Fasihul Alam
    Other supervisor: Dr Darren Edwards

Career History

Start Date End Date Position Held Location
2005 2014 Research Fellow /Senior Research Fellow University of South Wales, UK
2004 2005 Post-doc Research Fellow Brunel University, UK
1995 2003 Lecturer/Assistant Professor in Statistics University of Chittagong, Bangladesh

Key Grants and Projects

  • GP use of a C-Reactive point of care test (POCT) to help target antibiotic prescribing to acute COPD patients who are most likely to benefit (The PACE Study) 2014 - 2017

    , NIHR HTA - £1,634,313

  • Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer: ROCS (Radiotherapy after Oesophageal Cancer Stenting) Study 2013 - 2018

    , £1,756,379

  • RCT of all-Wales Licensed Premises Intervention to Reduce Alcohol-Related Violence 2011 - 2014

    , NIHR Public Health Programme - £653,849

  • Evaluation of the NHS Wales Community Pharmacy Discharge Medicines Review Service 2013 - 2014

    , Community Pharmacy Wales - £99,405